Sat, 17th Apr 2021 22:57
April 17 (Reuters) - A second person in Canada has
experienced rare blood clots with low platelets after
immunization with AstraZeneca's COVID-19 vaccine, the
Public Health Agency of Canada said on Saturday.
The agency said in a statement it received the report about
an individual in Alberta. The agency added that such reports
remain very rare.
(Reporting by Kanishka Singh in Bengaluru; Editing by Cynthia
Osterman)
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...
(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...
June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...
Astrazeneca (AZN)